1. Home
  2. TC vs XLO Comparison

TC vs XLO Comparison

Compare TC & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TuanChe Limited

TC

TuanChe Limited

HOLD

Current Price

$1.85

Market Cap

58.1M

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$9.04

Market Cap

56.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TC
XLO
Founded
2010
2016
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.1M
56.9M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
TC
XLO
Price
$1.85
$9.04
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
93.1K
8.7K
Earning Date
03-28-2025
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$43,766,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$168.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
589.88
52 Week Low
$1.49
$0.46
52 Week High
$19.99
$9.90

Technical Indicators

Market Signals
Indicator
TC
XLO
Relative Strength Index (RSI) 41.06 49.96
Support Level $1.87 $8.52
Resistance Level $2.69 $9.22
Average True Range (ATR) 0.10 0.31
MACD 0.04 0.01
Stochastic Oscillator 24.00 40.91

Price Performance

Historical Comparison
TC
XLO

About TC TuanChe Limited

Token Cat Ltd has two reportable business segments: automotive electronics resale business and advertising business. The automotive electronics resale business focuses on sourcing, holding, and reselling automotive electronics products, and includes sales of automotive electronic component equipment and accessories, mainly consisting of communication device and power module. The Company procures products from third-party suppliers and resells them to customers through its sales channels. The advertising business currently consists mainly of proxy advertising services, through which the Company helps clients promote their brands, services and products on third-party online platforms. The automotive electronics resale business segment generates maximum revenue.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: